Article
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.
Journal of inherited metabolic disease - 1 Jan 2018
Arends Maarten, Körver Simon, Hughes Derralynn A, Mehta Atul, Hollak Carla E M, Biegstraaten Marieke
Abstract excerpt
Quality of life (QoL) is decreased in patients with Fabry disease (FD). To improve QoL, it is important to understand the influence of FD related characteristics, symptoms, and complications. In this retrospective cohort study we explored the effect of pain (measured by the Brief Pain Inventory), phenotype, treatment, and FD-related complications on QoL. QoL data of Fabry patients as assessed by the EuroQol five...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
